Page last updated: 2024-08-24

gemcitabine and px 478

gemcitabine has been researched along with px 478 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Gao, S; Hao, J; Huang, C; Jia, L; Li, J; Qian, D; Ren, H; Wang, X; Xin, W; Yan, F; Zhao, T	1

Other Studies

1 other study(ies) available for gemcitabine and px 478

Article	Year
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. Oncotarget, 2015, Feb-10, Volume: 6, Issue:4 Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Death; Cell Line, Tumor; Deoxycytidine; DNA-Binding Proteins; Drug Synergism; Gemcitabine; HMGB1 Protein; Hypoxia-Inducible Factor 1, alpha Subunit; Immunization; Mice, Inbred C57BL; Mice, Nude; Microscopy, Fluorescence; Mustard Compounds; Pancreatic Neoplasms; Phenylpropionates; Phosphorylation; Survival Analysis; T-Lymphocytes; Transcription Factors; Tumor Burden	2015

Article

Year

Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.

Oncotarget, 2015, Feb-10, Volume: 6, Issue:4

Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Death; Cell Line, Tumor; Deoxycytidine; DNA-Binding Proteins; Drug Synergism; Gemcitabine; HMGB1 Protein; Hypoxia-Inducible Factor 1, alpha Subunit; Immunization; Mice, Inbred C57BL; Mice, Nude; Microscopy, Fluorescence; Mustard Compounds; Pancreatic Neoplasms; Phenylpropionates; Phosphorylation; Survival Analysis; T-Lymphocytes; Transcription Factors; Tumor Burden

2015